Obesity risks to children's hearts
09 November 2007
Cardiovascular damage due to obesity can be seen in children as young as seven, according to US researchers.
GPs should monitor BMI in children annually, especially between the ages of three and seven, the team told the American Heart Association scientific sessions in Orlando, Florida, last week.
Over this time 'BMI rebound' occurs. This is when BMI reaches its lowest point before increasing through later childhood.
The data from Cincinnati Children's Hospital in Ohio shows early BMI rebound is linked to a host of adverse cardiovascular outcomes that are evident in seven-year-olds.
The study involved 308 three-year-old children.
Early BMI rebound age, the lowest quartile, was put at 4.4 years for boys and 4.2 years for girls. Late rebound, the upper quartile, was 6.6 for boys and 5.7 for girls.
At age seven it was found in both sexes that early BMI rebound led to higher BMI, higher BP, increased levels of insulin and leptin, as well as a higher left ventricular mass and left atrial size.
Comment below and tell us what you thinkAdditional Information

Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Newly qualified GP's dr-locums £70 an hour plus, Nationwide
- Full Time Partner (9 sessions) Charnwood Community Medical Group Equal share partner, Loughborough, LEICS
- Locum GP Meddoc Locums £600-£800 A day, London & Essex
Most read
- Health secretary says GPs have 'ethical duty' to save NHS costs
- GPs face 'outcomes targets overload', patient group warns
- LMCs Conference 2012 - Live Blog
- QOF errors trigger £1,000 top ups and clawbacks
- Women to be screened later for cervical cancer in Scotland and Wales
- LMCs conference 2012 - Full coverage
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.







